High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Summary

This is a National Institutes of Health (NIH/NIDA) R01 funding opportunity announcement (FOA) focused on high-priority research at the intersection of HIV and substance use. Clinical trials are optional under this mechanism. The opportunity is open for multiple submission cycles spanning from August 2024 through March 2027, reflecting a standing/recurring FOA. Applicants are expected to propose investigator-initiated research projects addressing HIV prevention, treatment, or related substance use topics deemed high priority by NIDA.

How they evaluate

Risks & flags

• Minimal detail provided in source text — scope, evaluation criteria, budget limits, and key personnel requirements are not specified; full FOA should be reviewed on NIH Grants.gov or NIDA website before drawing conclusions about competitiveness or wiring.